Joe Compton, Sr Director Business Development and Alliance Management at Tjoapack, sat down with BioPharm International to discuss how the rapid growth of the biologics market is fueling innovation in packaging solutions, while also introducing complex challenges in ensuring cost-effectiveness and patient safety amid the rising demand for personalized therapies.

The rapid growth of the biologics market, projected to reach $817.48 billion by2032, is driving innovation in packaging solutions. The increasing demand for biosimilars, personalized therapies, and patient-centric drug delivery methods necessitates advanced, cost-effective packaging. Key trends include specialized packaging for biosimilars and biobetters, flexible solutions for personalized medicines, and the rise of self-administration via pre-filled syringes and autoinjectors.

Challenges such as stability, sterility, and counterfeit protection require innovative materials and regulatory compliance.

Partnering with specialized contract packaging organizations (CPOs) can enhance efficiency, safety, and cost-effectiveness, ensuring wider accessibility to life-saving biologics.

Read the full article here.